Field Trip Health & Wellness Ltd. (TSX-V: FTHW) ("Field Trip"
or the “Company”), a global leader in the delivery of psychedelic
therapies, today launched Freedom by Field Trip™ (the “Program”), a
first-of-its-kind one-year hybrid ketamine therapy program that
blends the power of psychedelic-assisted therapies with holistic
wellness support such as meditations, nutrition classes,
integration therapy, breathwork, somatic movement therapy,
community talks, and membership events. The Program, which offers
people the ability to participate in ketamine therapy at-home or in
one of Field Trip’s locations, is designed to increase
accessibility to psychedelic-assisted therapy for those suffering
from mild to moderate depression, anxiety, and trauma and support
it with a holistic approach to mental health and well-being.
“When you live in a world where a quarter of
your community will experience depression, yet antidepressants
perform no better than placebo in 85 percent of cases1, we don’t
just need new medicines, we need a whole new approach to mental
health,” said Ronan Levy, Chairman and CEO of Field Trip. “With our
current immersive in-person ketamine-assisted therapies, 93 percent
of our clients experience noticeable improvement immediately after
treatment, and the majority of clients sustain their progress for
more than four months. This led us to launch Freedom by Field
Trip™, which enables us to expand beyond our physical footprint and
amplify the power of our therapies with flexibility, accessibility
and a truly holistic approach to healing.”
The Program provides up to 12 at-home or
in-person ketamine exploration dosing sessions per year, medical
supervision to customize the ketamine explorations and one-on-one
integration therapy sessions as well as unlimited group integration
sessions with licensed therapists.
Uniquely, the Program is divided into three
“chapters” that are intentionally delivered on a week-by-week basis
to optimize the effects of the ketamine, enhance neuroplasticity
(the brain’s ability to heal and form new neural connections) and
improve mental wellness:
- Chapter 1: Awaken
- in months 1-3, clients follow Field Trip’s evidence-based
ketamine-assisted therapy protocol and begin with six low-dose
ketamine explorations designed to prompt introspective thinking and
remove mental obstacles, supported by integration therapy,
journaling, meditation, and wellness classes.
- Chapter 2:
Strengthen: in months 4-6, through continued classes,
one-on-one therapy, group integration circles, and daily practice,
clients will create and strengthen healthier thought patterns and
experience an increase in neuroplasticity.
- Chapter 3: Deepen:
in months 7 - 12, clients will continue weekly wellness programming
and, subject to medical approval, complete six additional ketamine
explorations to enhance personal growth, extend the results of
treatment, and solidify the progress that has been made.
“Freedom by Field Trip™ redefines how we think
about treating depression, anxiety, trauma and other mental health
conditions. It not only democratizes access to psychedelic
therapies by providing flexibility of location and an affordable
monthly membership-based fee structure, it also breaks down the
walls between different healing modalities and unites them in a
single program,” added Dr. Monique Moller, a practicing physician
at Field Trip and the Company's Vice President of Integrated
Health. “While there is no magic bullet for mental health, this is
the kind of innovation the world needs: the power of psychedelic
therapies combined with other healing modalities, all with
significantly fewer barriers. It gives people the freedom to access
deeper, more complete healing so they can live their lives free of
depression, anxiety and trauma.”
Freedom by Field Trip™ will initially be
available in California and Washington State and the Company
expects to rollout to additional jurisdictions in 2023. At launch,
the monthly fee for the Program will be $299.
For more information, visit
https://www.fieldtriphealth.com/.
About Field Trip Health & Wellness Ltd.
With a large global community of
psychedelic-interested people, proprietary psychedelic therapies
that generate transformative results for people in the treatment of
mental health conditions and a brand and share of voice that is
reaching millions of people, Field Trip is a center of gravity for
the psychedelic renaissance.
Learn more at https://www.meetfieldtrip.com,
https://www.fieldtriphealth.com and
https://www.fieldtriphealth.nl.
Follow us on Twitter and Instagram:
@fieldtriphealth
To receive company updates about Field Trip and
to be added to the email distribution list please sign up here.
Download Field Trip’s app here.
Cautionary Note Regarding Forward-Looking
Information.
This release includes forward-looking
information (within the meaning of Canadian securities laws)
regarding the Company and its business. Often but not always,
forward-looking information can be identified by the use of words
such as "expect", "intends", "anticipated", "believes" or
variations (including negative variations) of such words and
phrases, or state that certain actions, events or results "may",
"could", "would" or "will" be taken, occur or be achieved. Such
statements are based on the current expectations and views of
future events of the management of the Company and are based on
assumptions and subject to risks and uncertainties. Although
management believes that the assumptions underlying these
statements are reasonable, they may prove to be incorrect. The
forward-looking events and circumstances discussed in this release
may not occur and could differ materially as a result of known and
unknown risk factors and uncertainties affecting the companies,
including sign-ups, downloads, engagement, reviews, ability of
Field Trip to realize its business plan, grow its client base or
app user base, use of the Field Trip application by users, uptake
in existing or new programs by clinicians or patients, if any,
acceptance of psychedelic treatments by clinicians, patients, and
regulators, ability or effect of any clinical restructuring, future
changes in regulatory regimes which govern Field Trip’s business,
and/or the ability of Field Trip to realize on its business plan
for broadened, holistic approach to mental health and wellbeing.
Although the Company has attempted to identify important factors
that could cause actual actions, events or results to differ
materially from those described in forward-looking statements,
there may be other factors that cause actions, events or results to
differ from those anticipated, estimated or intended. Accordingly,
readers should not place undue reliance on any forward-looking
statements or information. No forward-looking statement can be
guaranteed. Except as required by applicable securities laws,
forward-looking statements speak only as of the date on which they
are made and the Company does not undertake any obligation to
publicly update or revise any forward-looking statement, whether as
a result of new information, future events, or otherwise.
Additional information relating to the Company, can be located on
the SEDAR website at www.sedar.com .
This press release does not constitute an offer to sell or the
solicitation of an offer to buy securities.
Neither the TSX Venture Exchange nor its Regulation Services
Provider, have approved the contents of this release or accept
responsibility for the adequacy or accuracy of this release.
CONTACTS:
Field Trip Health & Wellness:Ronan
LevyChairman & CEO (416) 505-0929ronan@fieldtriphealth.com
Media contacts:Isabella MorrealeAutumn
Communications(862) 579-7944press@fieldtriphealth.com
Investor contacts:Phil Carlson / Sophia
Bashford (646) 573-0776 / (929) 246-7307KCSA Strategic
CommunicationsfieldtripIR@kcsa.com
SOURCE Field Trip Health & Wellness Ltd.
__________________________1 BMJ 2022;378:e067606,
https://www.bmj.com/content/378/bmj-2021-067606.
Field Trip Health and We... (TSXV:FTHW)
Historical Stock Chart
From Mar 2024 to Apr 2024
Field Trip Health and We... (TSXV:FTHW)
Historical Stock Chart
From Apr 2023 to Apr 2024